NAD+ vs NMN is not a contest between two rival products. NAD+ is the coenzyme your cells actually use, and NMN is a precursor your body converts into it. The practical comparison is an oral supplement against prescription compounded NAD+.
Most content treats NAD and NMN as competing versions of one thing. One is the destination and the other is a route to it. Once that is clear, the real question is about absorption and regulation.
NAD+ and NMN Sit at Different Points on One Pathway
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is central to redox reactions and mitochondrial energy production, and it is consumed as a substrate by enzymes including sirtuins and PARPs, which is why it appears in DNA repair and cellular ageing research.
NMN (nicotinamide mononucleotide) is not that. It is one of several precursors, alongside nicotinamide riboside (NR), nicotinic acid and nicotinamide, that cells convert into NAD+ through salvage pathways. NMN sits one enzymatic step upstream, converted to NAD+ by NMNAT enzymes.
So an NMN supplement is not NAD+ in a capsule. It is raw material for a conversion your cells already run. NAD+ levels are widely reported to decline with age, a research observation rather than a promise that raising them produces any particular outcome.
One correction: neither molecule is a peptide, despite how often "nad peptide" gets searched. We cover that in Is NAD a peptide?, with the basics in What is NAD+?
Why Precursors Became the Dominant Supplement Approach
If NAD+ is what cells use, the obvious product would be oral NAD+. The supplement industry did not go that way, for a specific reason.
NAD+ is a large, charged molecule with poor oral bioavailability. A 2023 review in Advances in Nutrition puts it bluntly, stating that because NAD+ cannot be absorbed orally or pass through the cell membrane, raising NAD+ concentrations is instead approached by supplementing with its precursors.
Precursors exist because the coenzyme itself does not survive the oral route intact. That single constraint explains the entire NMN supplement category, and it explains why prescription NAD+ uses routes that skip the gut, such as intranasal spray, injection or intravenous infusion.
NAD+ vs NMN: A Direct Comparison
| NAD+ (the coenzyme) | NMN (a precursor) | |
|---|---|---|
| What it is | Coenzyme present in every living cell | Molecule the body converts into NAD+ |
| Oral absorption | Not absorbed orally intact, per published review | Absorbed orally, and studied that way in trials |
| Routes commonly used | Intranasal spray, injection, intravenous infusion | Capsules, tablets or powder |
| US regulatory category | Prescription compounded medication; not FDA-approved | Dietary supplement; not FDA-approved to treat anything |
| Who sets the amount | A licensed provider, after reviewing your intake | The manufacturer sets the serving size |
| Human evidence base | Limited and preliminary for intranasal delivery | Several randomized trials, mostly small and short |
| How you obtain it | Prescription only, subject to provider approval | Over the counter, no prescription involved |
The table does not crown a winner. Each column answers a different question.
If the prescription side of this comparison is the one you want assessed properly, a licensed provider can review your history and decide whether compounded NAD+ is appropriate for you.
See NAD+ nasal spray at telos rxWhat Human Research on NMN Has Established, and What It Has Not
NMN deserves credit here rather than dismissal. The precursor approach has actually been tested in humans.
A randomized, multicenter, double-blind, placebo-controlled trial published in Geroscience in 2023 gave 80 healthy middle-aged adults a daily placebo or 300 mg, 600 mg or 900 mg of NMN over 60 days. Blood NAD concentrations rose significantly in every NMN group compared with both placebo and baseline, measured at day 30 and day 60 of the study.
Those figures describe what investigators administered to a study population under trial conditions. They appear here as study design, not as a suggested amount for anyone reading this, and nothing in this article is guidance on what to take.
That establishes something real: oral NMN raises blood NAD in study populations. It is a measurable biochemical finding, not marketing.
What it does not establish is the harder part. The 2023 Advances in Nutrition review notes that published NMN trials have mostly enrolled between 8 and 66 participants, sit at roughly phase I level, run for short periods, and examine a narrow set of endpoints. Long-term safety and durable clinical outcomes remain open questions.
Raising a blood marker and changing how someone functions over years are different claims. The first has support. The second does not yet, for NMN or for NAD+ alike.
A Supplement and a Prescription Medication Are Regulated Differently
This part of the comparison rarely gets covered, and it changes what each option means in practice.
Under the Dietary Supplement Health and Education Act, the FDA explains that it does not have authority to approve dietary supplements before they are marketed. Manufacturers and distributors carry initial responsibility for meeting safety standards, and the agency is generally limited to postmarket enforcement. Serving size, the FDA notes, is decided by the manufacturer and does not require FDA approval.
None of that makes supplements worthless. It does mean accountability sits differently than on the prescription side, where a clinician reviews an individual patient.
Compounded NAD+ is not FDA-approved either. It is prepared by licensed US compounding pharmacies against a prescription written for a specific patient. NAD+ is not FDA-approved for anti-ageing, longevity, energy or any wellness indication. The difference is not that one is approved and the other is not. Neither is. The difference is who is accountable, and whether a clinician is involved at all.
Where Delivery Route Enters the Picture
Because NAD+ is not absorbed orally intact, prescription NAD+ uses routes that bypass the gut. Intranasal delivery carries a drug across the nasal mucosa and avoids first-pass hepatic metabolism.
Being straight about the evidence matters here. Published human research on intranasal NAD+ specifically is limited and preliminary next to the oral precursor literature, and no published head-to-head trial compares NMN supplementation against intranasal NAD+.
The route comparisons have their own pieces: NAD+ nasal spray: how it works, NAD+ supplements vs nasal spray, nasal spray vs IV therapy and nasal spray vs injections.
If your question is instead which precursor has more behind it, that is a different comparison, answered in NMN vs NR. This page sets the precursor idea against NAD+ itself; that one sets two precursors against each other.
How a Provider Approaches the Choice
A provider does not start from which molecule is trendier. They start from your history, medications, labs and goals, then decide whether a prescription is appropriate at all.
At telos rx the process is online-first and asynchronous, so there is no appointment to schedule. You complete a written intake, a licensed provider reviews it, often within hours, and responds in writing. Everything is subject to medical approval by a licensed provider, and approval is not guaranteed.
Where a provider does prescribe, telos rx supplies compounded NAD+ as an intranasal spray used at home. The amount and schedule are set by the prescribing provider, not chosen from an article, which is why no spray count appears here. Service covers all 50 states through a network of licensed US compounding pharmacies, and formulation can vary by state.
As of publication, the NAD+ nasal spray page lists pricing as low as $116 per month against a $249 list price, depending on plan length. Free 48-hour shipping if approved, FSA and HSA accepted, cancel anytime. telos rx is LegitScript-certified.
Keep Reading
- What Is NAD+? Meaning, Function, Benefits, and Safety
- NAD+ Nasal Spray Dosage: What a Provider Decides
- How to Increase NAD+ Levels: A Step-by-Step Guide
Frequently Asked Questions
What is the difference between NAD+ and NMN?
NAD+ is the coenzyme cells use directly in energy metabolism and repair processes. NMN is a precursor one enzymatic step upstream, which cells convert into NAD+ through salvage pathways. They are not competing versions of one substance. NMN is raw material for a conversion your body already performs.
Is NMN the same as NAD?
No. They are chemically distinct molecules with different roles. NMN is nicotinamide mononucleotide, a precursor. NAD+ is nicotinamide adenine dinucleotide, the coenzyme. Taking an NMN supplement is not the same as taking NAD+, and pages using the terms interchangeably blur a distinction that affects both absorption and regulation.
Is NMN better than NAD+?
Neither is straightforwardly better, because they are not the same kind of product. NMN has more published human trial data, though those trials are mostly small and short. Prescription compounded NAD+ carries clinician oversight but a thinner published evidence base for non-oral routes. A licensed provider can weigh which suits your situation.
Does an NMN supplement actually raise NAD+ levels?
In study populations, yes. A randomized placebo-controlled trial published in Geroscience in 2023 gave 80 healthy middle-aged adults 300, 600 or 900 mg of NMN daily and reported significantly higher blood NAD concentrations than placebo at day 30 and day 60. Those amounts describe the trial design and are not a suggested amount for any reader. Whether that translates into durable clinical outcomes has not been established.
Is NMN FDA-approved?
No. NMN is sold as a dietary supplement and is not FDA-approved to treat anything. The FDA does not approve dietary supplements before they are marketed, and manufacturers carry initial responsibility for safety. Compounded NAD+ is also not FDA-approved. It is prepared by licensed US compounding pharmacies under federal compounding regulations against an individual prescription.
Do you need a prescription for NAD+?
Compounded NAD+ from telos rx is prescription-only and requires review by a licensed provider before it can be dispensed. NMN supplements are sold over the counter. That difference in access also reflects a difference in oversight, since a prescription involves a clinician evaluating your individual history and medications first.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
If you want the prescription side of this comparison evaluated for your situation, start with the NAD+ nasal spray product page, then complete the written intake here: start an online visit for NAD+. A licensed provider reviews every request, and approval is not guaranteed.